Shanghai Shenqi Pharmaceutical Investment Management Co Ltd Class A 600613
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 6.58
- Day Range
- CNY 6.52–6.61
- 52-Week Range
- CNY 4.65–9.31
- Bid/Ask
- CNY 6.54 / CNY 6.55
- Market Cap
- CNY 3.50 Bil
- Volume/Avg
- 4.5 Mil / 8.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- 45.55
- Price/Sales
- 1.46
- Dividend Yield (Trailing)
- 1.51%
- Dividend Yield (Forward)
- 1.51%
- Total Yield
- 1.52%
Company Profile
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd is mainly engaged in pharmaceutical production and distribution in China.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,426
- Website
- http://www.gzsq.com
Comparables
Valuation
|
Metric
|
600613
|
002433
|
002693
|
|---|---|---|---|
Price/Earnings (Normalized) | 45.55 | — | — |
Price/Book Value | 1.49 | 1.03 | 5.17 |
Price/Sales | 1.46 | 1.16 | 12.34 |
Price/Cash Flow | 14.54 | — | 308.87 |
Price/Earnings
600613
002433
002693
Financial Strength
|
Metric
|
600613
|
002433
|
002693
|
|---|---|---|---|
Quick Ratio | 2.25 | 0.23 | 0.44 |
Current Ratio | 2.67 | 0.49 | 0.74 |
Interest Coverage | 7.07 | −10.04 | −0.28 |
Quick Ratio
600613
002433
002693
Profitability
|
Metric
|
600613
|
002433
|
002693
|
|---|---|---|---|
Return on Assets (Normalized) | 2.40% | −20.42% | −4.75% |
Return on Equity (Normalized) | 3.33% | −46.06% | −8.05% |
Return on Invested Capital (Normalized) | 3.14% | −26.92% | −4.32% |
Return on Assets
600613
002433
002693
Drug Manufacturers - General Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
LLY
| Eli Lilly and Co | Fbzpqswt | Rwz | $732.9 Bil | |
JNJ
| Johnson & Johnson | Xgdmpdrn | Mbs | $372.2 Bil | |
MRK
| Merck & Co Inc | Rmnksxhp | Ybj | $332.3 Bil | |
ABBV
| AbbVie Inc | Cjblqjfq | Wmrz | $290.2 Bil | |
AZN
| AstraZeneca PLC ADR | Jdjbrptrf | Gvvmj | $237.9 Bil | |
RHHBY
| Roche Holding AG ADR | Tkglylnst | Ntbj | $211.1 Bil | |
NVS
| Novartis AG ADR | Lsqhhbyv | Czm | $210.2 Bil | |
AMGN
| Amgen Inc | Hnvyfxcr | Ntsj | $167.6 Bil | |
PFE
| Pfizer Inc | Yvsggkzql | Jwwv | $162.3 Bil | |
SNY
| Sanofi SA ADR | Pptrkxph | Dnl | $121.1 Bil |